IOSP vs TECH · P/E 18, rev $1.78B vs P/E 65, rev $1.22B
Innospec Inc (IOSP) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Innospec Inc (IOSP) is a specialty chemicals company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported IOSP revenue for 2025-12-31 was $1.78B. Net income was $116.6M. Revenue was down 3.7% from 2024-12-31 to 2025-12-31. IOSP currently screens at market cap $2.05B and trailing P/E 18.1.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
IOSP currently screens at market cap $2.05B and trailing P/E 18.1. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the IOSP and TECH stock pages for the full models.
Not investment advice.